Lipella Pharmaceuticals Inc. announced that it will receive $122,400 in funding on July 10, 2023. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. The company will issue 60,000 shares at an issue price of $2,04 per share for the gross proceeds of $122,400.

The transaction will include participation from single investor.